Is Common Denominator Lead to Misdiagnosis of Dementia and Late-Life Depression
(1) * Seyyide Şifa Göktaş Mail (University of Health Sciences, Turkey)
*corresponding author

Abstract


Significant cognitive impairments are found in late life depression. This situation brings to mind the question of what are the common and distinct mechanisms of late life depression and dementia. In this review, neural and psychological mechanism are discussed within the scope of denominator and hallmark for both disorders. It is searched several databases e.g. MEDLINE, Web of Science Core Collection from 1974 to 2024 by using variant terms for the focal epilepsy subtypes and social cognition constructs. The pathology of dementia was correlated with late-life depression Studies indicate that depression may be an etiological factor for dementia as well as an increased risk. Also, many life-related stressors can lead to results such as increased reactive oxygen species, inflammatory responses, suppression of neurogenesis, and apical dendritic atrophy and altered functional connectivity in the medial prefrontal cortex. Based on this, it is possible to say that psychological stress factors increase the incidence of the disease in the development of dementia, just like in depression. Late depression should not be labeled as dementia because of they share similar symptoms and should be evaluated clinically correct so that it is not misdiagnosed. Besides, it is substantial to comprehend the relationship between the aging population and the risk of depression and dementia for current and future studies, especially in terms of prevention and treatment.


Keywords


late-life depression; dementia; Alzheimer disease; mild cognitive impairment; biological aging; imaging; hippocampus volume; gray matter; stress hormones

   

DOI

https://doi.org/10.47679/jopp.627582024 		      

Article metrics

Read: 817 | Download: 606

   

Cite

How to cite item
   

Full Text

Download

References


AIHW. (2023). Dementia in Australia. Australian Institute of Health and Welfare. Accessed December 16, 2023. https://www.aihw.gov.au/reports/dementia/dementia-in-aus

Aldwin, C. M., Sutton, K. J., Chiara, G., & Spiro, A. (1996). Age differences in stress, coping, and appraisal: Findings from the Normative Aging Study. The Journals of Gerontology, Series B, 51(4), P179-P188.

Alexopoulos, G. S. (2000). Mood disorders. In Comprehensive Textbook of Psychiatry (pp. 3060-3067). Philadelphia: Lippincott Williams & Wilkins.

Alexopoulos, G. S., Meyers, B. S., Young, R. C., Mattis, S., & Kakuma, T. (1993). The course of geriatric depression with" reversible dementia": A controlled study. American Journal of Psychiatry, 150, 1693-1693.

Almeida, O. P., Hankey, G. J., Yeap, B. B., Golledge, J., & Flicker, L. (2017). Depression as a modifiable factor to decrease the risk of dementia. Translational psychiatry, 7(5), e1117-e1117.

American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM-5 (5th ed.). Washington, DC: American Psychiatric Publishing.

Arreola, R., Becerril-Villanueva, E., Cruz-Fuentes, C., Velasco-Velázquez, M. A., Garcés-Alvarez, M. E., Hurtado-Alvarado, G., Quintero-Fabian, S., & Pavón, L. (2015). Immunomodulatory effects mediated by serotonin. Journal of Immunology Research, 2015, Article ID 354957. https://doi.org/10.1155/2015/354957

Aziz, R., & Steffens, D. C. (2013). What are the causes of late-life depression? Psychiatric Clinics, 36(4), 497-516.

Berton, O., & Nestler, E. J. (2006). New approaches to antidepressant drug discovery: Beyond monoamines. Nature Reviews Neuroscience, 7(2), 137-151.

Blazer, D. G. (2003). Depression in late life: Review and commentary. The Journals Of Gerontology Series A: Biological Sciences and Medical Sciences, 58(3), M249-M265.

Borroto-Escuela, D. O., Ambrogini, P., Chruścicka, B., Lindskog, M., Crespo-Ramirez, M., Hernández-Mondragón, J. C., ... & Fuxe, K. (2021). The role of central serotonin neurons and 5-HT heteroreceptor complexes in the pathophysiology of depression: A historical perspective and future prospects. International Journal of Molecular Sciences, 22(4), 1927.

Borsje, P., Wetzels, R. B., Lucassen, P. L., Pot, A. M., & Koopmans, R. T. (2015). The course of neuropsychiatric symptoms in community-dwelling patients with dementia: A systematic review. International Psychogeriatrics, 27(3), 385-405.

Brambilla, F. (2000). Psychoneuroendocrinology: research on the pituitary adrenal-cortical system. Psychosomat Medicine, 62, 576-607.

Brown, R. G., & Marsden, C. D. (1990). Cognitive function in Parkinson's disease: From description to theory. Trends in Neurosciences, 13(1), 21-29.

Burkhardt, J. M., Jin, X., & Costa, R. M. (2009). Dissociable effects of dopamine on neuronal firing rate and synchrony in the dorsal striatum. Frontiers in İntegrative Neuroscience, 28.

Butters, M. A., Young, J. B., Lopez, O., Aizenstein, H. J., Mulsant, B. H., Reynolds III, C. F., ... & Becker, J. T. (2008). Pathways linking late-life depression to persistent cognitive impairment and dementia. Dialogues in Clinical Neuroscience, 10(3), 345-357.

Büchtemann, D., Luppa, M., Bramesfeld, A., & Riedel-Heller, S. (2012). Incidence of late-life depression: a systematic review. Journal of Affective Disorders, 142(1-3), 172-179.

Cairney, S. A., El Marj, N., & Staresina, B. P. (2018). Memory consolidation is linked to spindle-mediated information processing during sleep. Current Biology, 28(6), 948-954.

Campbell, S., & MacQueen, G. (2004). The role of the hippocampus in the pathophysiology of major depression. Journal of Psychiatry and Neuroscience, 29(6), 417-426.

Cassano, P., & Fava, M. (2002). Depression and public health: an overview. Journal of Psychosomatic Research, 53(4), 849-857.

Checkley, S. (1996). The neuroendocrinology of depression. International Review of Psychiatry, 8(4), 373-378.

Dellarole, A., Morton, P., Brambilla, R., Walters, W., Summers, S., Bernardes, D., ... & Bethea, J. R. (2004). Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling. Brain, behavior, and immunity, 41, 65-81.

Desmyter, S., Van Heeringen, C., & Audenaert, K. (2011). Structural and functional neuroimaging studies of the suicidal brain. Progress in neuro-psychopharmacology and biological psychiatry, 35(4), 796-808.

Dillon, C., Serrano, C. M., Castro, D., Leguizamón, P. P., Heisecke, S. L., & Taragano, F. E. (2013). Behavioral symptoms related to cognitive impairment. Neuropsychiatric Disease and Treatment, 9, 1443.

Diniz, B. S., Butters, M. A., Albert, S. M., Dew, M. A., & Reynolds, C. F. (2013). Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. The British Journal of Psychiatry, 202(5), 329-335.

Dişcigil, G. (2013). Kadın ve demans. Türkiye Klinikleri Aile Hekimliği Özel Dergisi, 4, 88-93.

Dorszewska, J., Prendecki, M., Oczkowska, A., Dezor, M., & Kozubski, W. (2016). Molecular basis of familial and sporadic Alzheimer's disease. Current Alzheimer Research, 13(9), 952-963.

Drevets, W. C. (2001). Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology, 11(2), 240-249.

Duman, R. S., Aghajanian, G. K., Sanacora, G., & Krystal, J. H. (2016). Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nature Medicine, 22(3), 238-249.

Enache, D., Winblad, B., & Aarsland, D. (2011). Depression in dementia: epidemiology, mechanisms, and treatment. Current Opinion in Psychiatry, 24(6), 461-472.

Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., Van Swieten, J. C., ... & Breteler, M. M. (2004). Inflammatory proteins in plasma and the risk of dementia: the rotterdam study. Archives of Neurology, 61(5), 668-672.

Fee, C., Banasr, M., & Sibille, E. (2017). Somatostatin-positive gamma-aminobutyric acid interneuron deficits in depression: cortical microcircuit and therapeutic perspectives. Biological Psychiatry, 82(8), 549-559.

Fereshtehnejad, S. M., Zeighami, Y., Dagher, A., & Postuma, R. B. (2017). Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain, 140(7), 1959-1976.

Fjell, A. M., Walhovd, K. B., Fennema-Notestine, C., McEvoy, L. K., Hagler, D. J., Holland, D., ... & Dale, A. M. (2009). One-year brain atrophy evident in healthy aging. Journal of Neuroscience, 29(48), 15223-15231.

Gatz, M., Mortimer, J. A., Fratiglioni, L., Johansson, B., Berg, S., Andel, R., ... & Pedersen, N. L. (2007). Accounting for the relationship between low education and dementia: a twin study. Physiology & Behavior, 92(1-2), 232-237.

Geerlings, M. I., Sigurdsson, S., Eiriksdottir, G., Garcia, M. E., Harris, T. B., Gudnason, V., & Launer, L. J. (2015). Salivary cortisol, brain volumes, and cognition in community-dwelling elderly without dementia. Neurology, 85(11), 976-983.

Ghosal, S., Hare, B. D., & Duman, R. S. (2017). Prefrontal cortex GABAergic deficits and circuit dysfunction in the pathophysiology and treatment of chronic stress and depression. Current Opinion in Behavioral sciences, 14, 1-8.

Giovannetti, E. A., & Fuhrmann, M. (2019). Unsupervised excitation: GABAergic dysfunctions in Alzheimer’s disease. Brain Research, 1707, 216-226.

Glenner, G. G., & Wong, C. W. (1984). Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochemical and Biophysical Research Communications, 120(3), 885-890.

Göthert, M. (2013). Serotonin discovery and stepwise disclosure of 5-HT receptor complexity over four decades. Part I. General background and discovery of serotonin as a basis for 5-HT receptor identification. Pharmacological Reports, 65(4), 771-786.

Haigh, E. A., Bogucki, O. E., Sigmon, S. T., & Blazer, D. G. (2018). Depression among older adults: A 20-year update on five common myths and misconceptions. The American Journal of Geriatric Psychiatry, 26(1), 107-122.

Hall, B. S., Moda, R. N., & Liston, C. (2015). Glucocorticoid mechanisms of functional connectivity changes in stressrelated neuropsychiatric disorders. Neurobiol Stress, 1, 174-83.

Hanger, D. P., Anderton, B. H., & Noble, W. (2009). Tau phosphorylation: The therapeutic challenge for neurodegenerative disease. Trends in Molecular Medicine, 15(3), 112-119.

Hayley, S., Audet, M. C., & Anisman, H. (2016). Inflammation and the microbiome: Implications for depressive disorders. Current Opinion in Pharmacology, 29, 42-46.

Hebert, L. E., Weuve, J., Scherr, P. A., & Evans, D. A. (2013). Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology, 80(19), 1778-1783.

Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., ... & Myers, B. (2016). Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comprehensive Physiology, 6(2), 603.

Hickie, I., Naismith, S., Ward, P. B., Turner, K., Scott, E., Mitchell, P., ... & Parker, G. (2005). Reduced hippocampal volumes and memory loss in patients with early-and late-onset depression. The British Journal of Psychiatry, 186(3), 197-202.

Hirvonen, J., Karlsson, H., Kajander, J., Lepola, A., Markkula, J., Rasi-Hakala, H., ... & Hietala, J. (2008). Decreased brain serotonin 5-HT 1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11 C] WAY-100635. The International Journal of Neuropsychopharmacology, 11(4), 465-476.

Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984). Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science, 225(4667), 1168-1170.

Işık, E., Işık, U., & Taner, Y. (2013). Çoçuk, ergen, erişkin ve yaşlılarda depresif ve bipolar bozukluklar. Ankara, Rotatıp Kitapevi.

Jarvik, L. F. (1976). Aging and depression: Some unanswered questions. Journal of Gerontology, 31(3), 324-326.

Jonker, C., Geerlings, M. I., & Schmand, B. (2000). Are memory complaints predictive for dementia? A review of clinical and population‐based studies. International Journal of Geriatric Psychiatry, 15(11), 983-991.

Karamustafalıoğlu, O., & Yumrukçal, H. (2011). Depresyon ve anksiyete bozuklukları. Şişli Etfal Hastanesi Tıp Bülteni, 45(2), 65-74.

Kelly, J., Sadeghieh, T. & Adeli, K. (2014). Peer review in scientific publications: benefits, critiques, & a survival guide. Ejifcc, 25(3), 227.

Kitching, D. (2015). Depression in dementia. Australian prescriber, 38(6), 209.

Korczyn, A. D., & Halperin, I. (2009). Depression and dementia. Journal of the Neurological Sciences, 283(1-2), 139-142.

Kok, P., Rahnev, D., Jehee, J. F., Lau, H. C., & De Lange, F. P. (2012). Attention reverses the effect of prediction in silencing sensory signals. Cerebral Cortex, 22(9), 2197-2206.

Köroğlu, E. (2008). Depresyon Nedir? Nasıl Başedilir? Ankara: Hyb Yayıncılık.

Krishnan, V., & Nestler, E. J. (2008). The molecular neurobiology of depression. Nature, 455(7215), 894-902.

Lauder, J. M., & Bloom, F. E. (1975). Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. Journal of Comparative Neurology, 163(3), 251-264.

Leonard, B. E. (1989). The amine hypothesis of depression: A reassessment. In B. E. Leonard (Ed.), Biochemical and Pharmacological Aspects of Depression (pp. 25-49). London, New York, and Philadelphia: Taylor & Francis Ltd.

Leonard, B. E. (1997). Noradrenaline in basic models of depression. European neuropsychopharmacology, 7(1), S11-S16.

Li, H., Hirano, S., Furukawa, S., Nakano, Y., Kojima, K., Ishikawa, A., ... & Kuwabara, S. (2020). The relationship between the striatal dopaminergic neuronal and cognitive function with aging. Frontiers in Aging Neuroscience, 12, 41.

Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., ... & Mukadam, N. (2017). Dementia prevention, intervention, and care. The Lancet, 390(10113), 2673-2734.

Lorenzetti, V., Allen, N. B., Fornito, A., & Yücel, M. (2009). Structural brain abnormalities in major depressive disorder: A selective review of recent MRI studies. Journal of Affective Disorders, 117(1-2), 1-17.

Lucassen, P. J. (2007). What causes the hippocampal volume decrease in depression? European Archives of Psychiatry and Clinical Neuroscience, 257(5), 250-260.

Maes, M. (1999). Major depression and activation of the inflammatory response system. Cytokines, Stress, and Depression, 25-46.

McLeod, J., Cooper, M., & Dryden, W. (2015). Helping clients address depression. The Handbook of Pluralistic Counselling and Psychotherapy, 173.

Meeks, T. W., Ropacki, S. A., & Jeste, D. V. (2006). The neurobiology of neuropsychiatric syndromes in dementia. Current Opinion in Psychiatry, 19(6), 581-586.

Meichsner F, Theurer C, Wilz G (2018) Acceptance and treatment effects of an internet‐delivered cognitive‐behavioral intervention for family caregivers of people with dementia: A randomized‐controlled trial. Journal of Clinical Psychology, 75, 594-613.

Mucke, L., Masliah, E., Yu, G. Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., ... & McConlogue, L. (2000). High-level neuronal expression of Aβ1–42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. Journal of Neuroscience, 20(11), 4050-4058.

Nelson, J. C., & Devanand, D. P. (2011). A Systematic Review and Meta‐Analysis of Placebo‐Controlled Antidepressant Studies in People with Depression and Dementia: [See Editorial Comments by Eric Lenze, MD on pp 0000–0000]. Journal of the American Geriatrics Society, 59(4), 577-585.

Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., ... & Vale, W. (1984). Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science, 226(4680), 1342-1344.

Nestler, E. J., & Carlezon Jr, W. A. (2006). The mesolimbic dopamine reward circuit in depression. Biological Psychiatry, 59(12), 1151-1159.

Ninan, P. T. (1999). The functional anatomy, neurochemistry, and pharmacology of anxiety. Journal of Clinical Psychiatry, 60, 12-17.

Özaşkınlı, S., Öztürk, Ö., Eraslan, D., & Bora, E. (2005). Yaşlılık ve depresyon. İçinde E. Bora (Ed.), Yaşlılık ve Psikiyatri (s. 15-24). İzmir: Çelikkol Yayıncılık.

Panza, F., Frisardi, V., Capurso, C., D'Introno, A., Colacicco, A. M., Imbimbo, B. P., ... & Solfrizzi, V. (2010). Late-life depression, mild cognitive impairment, and dementia: possible continuum? The American Journal of Geriatric Psychiatry, 18(2), 98-116.

Parmera, J. B., Brucki, S., & Nitrini, R. (2018). Reader response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology; 90(6), 299-300.

Prince, M., Guerchet, M., & Prina, M. (2014). Alzheimer’s Disease International (2013b) Policy Brief for Heads Of Government: The Global Impact of Dementia 2013-2050. Alzheimer's Disease International, London.

Prince, N. D., & Scheltens, P. (2015). White matter hyperintensities, cognitive impairment and dementia: An update. Nature Reviews Neurology, 11(3), 157-165.

Prinz, M., Jung, S., & Priller, J. (2019). Microglia biology: one century of evolving concepts. Cell, 179(2), 292-311.

Rapp, M. A., Dahlman, K., Sano, M., Grossman, H. T., Haroutunian, V., & Gorman, J. M. (2005). Neuropsychological differences between late-onset and recurrent geriatric major depression. American Journal of Psychiatry, 162(4), 691-698.

Regier, D. A., Boyd, J. H., Burke, J. D., Rae, D. S., Myers, J. K., Kramer, M., ... & Locke, B. Z. (1988). One-month prevalence of mental disorders in the United States: Based on five epidemiologic catchment area sites. Archives of General Psychiatry, 45(11), 977-986.

Rossor, M. N. (1996). Degenerative diseases. Current Opinion in Neurology, 9(4), 251-253.

Rushing, N. C., Sachs-Ericsson, N., & Steffens, D. C. (2014). Neuropsychological indicators of preclinical Alzheimer’s disease among depressed older adults. Aging, Neuropsychology, and Cognition, 21(1), 99-128.

Salib, E., & HILLIER, V. (1997). Head injury and the risk of Alzheimer's disease: A case control study. International Journal of Geriatric Psychiatry, 12(3), 363-368.

Samieri, C., Perier, M. C., Gaye, B., Proust-Lima, C., Helmer, C., Dartigues, J. F., ... & Empana, J. P. (2018). Association of cardiovascular health level in older age with cognitive decline and incident dementia. Jama, 320(7), 657-664.

Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007). Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology; 69(24), 2197-2204.

Schultz, W. (2007). Multiple dopamine functions at different time courses. Annual review of neuroscience, 30(1), 259-288.

Sheline, Y. I., Barch, D. M., Garcia, K., Gersing, K., Pieper, C., Welsh-Bohmer, K., ... & Doraiswamy, P. M. (2006). Cognitive function in late life depression: relationships to depression severity, cerebrovascular risk factors and processing speed. Biological Psychiatry, 60(1), 58-65.

Smith, G. S., Kramer, E., Ma, Y., Kingsley, P., Dhawan, V., Chaly, T., & Eidelberg, D. (2009). The functional neuroanatomy of geriatric depression. International Journal of Geriatric Psychiatry: A Journal of The Psychiatry of Late Life and Allied Sciences, 24(8), 798-808.

Sweet, R. A., Hamilton, R. L., Butters, M. A., Mulsant, B. H., Pollock, B. G., Lewis, D. A., ... & Reynolds, C. F. (2004). Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology, 29(12), 2242-2250.

Steffens, D. C., & Potter, G. G. (2008). Geriatric depression and cognitive impairment. Psychological Medicine, 38(2), 163-175.

Takahashi, R. H., Almeida, C. G., Kearney, P. F., Yu, F., Lin, M. T., Milner, T. A., & Gouras, G. K. (2004). Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. Journal of Neuroscience, 24(14), 3592-3599.

Tedeschini, E., Levkovitz, Y., Iovieno, N., Ameral, V. E., Nelson, J. C., & Papakostas, G. I. (2011). Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. The Journal of Clinical Psychiatry, 72(12), 5967.

Thieme, F. (2018). Vorzeitiges epigenetisches Altern bei Depression. Fortschr Neurol Psychiatr; 86, 677.

Van Uden, I. W., Tuladhar, A. M., de Laat, K. F., van Norden, A. G., Norris, D. G., van Dijk, E. J., ... & de Leeuw, F. E. (2015).White matter integrity and depressive symptoms in cerebral small vessel disease: the RUN DMC study. The American Journal of Geriatric Psychiatry, 23(5), 525-535.

Wais, P. E., Wixted, J. T., Hopkins, R. O., & Squire, L. R. (2006). The hippocampus supports both the recollection and the familiarity components of recognition memory. Neuron, 49(3), 459-466.

Wamsteeker, J. I., & Bains, J. S. (2010). A synaptocentric view of the neuroendocrine response to stress. European Journal of Neuroscience, 32(12), 2011-2021.

Wang, X., Yang, J., & Hashimoto, K. (2022). (R)-ketamine as prophylactic and therapeutic drug for neurological disorders: beyond depression. Neuroscience & Biobehavioral Reviews, 104762.

Ward, A., Arrighi, H. M., Michels, S., & Cedarbaum, J. M. (2012). Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimer's & Dementia, 8(1), 14-21.

Weber, R., Weimar, C., Blatchford, J., Hermansson, K., Wanke, I., Möller-Hartmann, C., ... & Profess. (2012). Imaging Substudy Group. Telmisartan on top of antihypertensive treatment does not prevent progression of cerebral white matter lesions in the prevention regimen for effectively avoiding second strokes (PRoFESS) MRI substudy. Stroke, 43(9), 2336-2342.

Weiner, M. F., & Lipton, A. M. (Eds.). (2008). The dementias: Diagnosis, treatment, and research. American Psychiatric Publishing.

Wells, C. E. (1979). Pseudodementia. American Journal of Psychiatry, 136(7), 895-900.

Wenk, G. L. (2003). Neuropathologic changes in Alzheimer's disease. Journal of Clinical Psychiatry, 64, 7-10.

West, M. J., Coleman, P. D., Flood, D. G., & Troncoso, J. C. (1994). Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. The Lancet, 344(8925), 769-772.

Wise, T., Radua, J., Via, E., Cardoner, N., Abe, O., Adams, T. M., ... & Arnone, D. (2017). Common and distinct patterns of grey-matter volume alteration in major depression and bipolar disorder: evidence from voxel-based meta-analysis. Molecular psychiatry, 22(10), 1455-1463.

Yüksel, N. (2009). Demansın nörobiyolojisi/Neurobiology of dementia. Anadolu Psikiyatri Dergisi, 10, S38.

Zgaljardic, D. J., Foldi, N. S., & Borod, J. C. (2004). Cognitive and behavioral dysfunction in Parkinson’s disease: Neurochemical and clinicopathological contributions. Journal of Neural Transmission, 111(10), 1287-1301.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Seyyide Şifa Göktaş

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Creative Commons License
All publications by the Utan Kayu Publishing [e-ISSN: 2715-4807, p-ISSN: 2715-4785] is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.